COMP <GO>
EMN vs LIN // NET PROFIT MARGIN
Eastman Chemical Company (NYSE) VS. Linde plc (NASDAQ) • 15-METRIC TALLY: EMN 5
— LIN 10
▲ NET PROFIT MARGIN LEADER: LIN
LAST: $66.53 (-2.06%) • MKT CAP: $7.77B
net-margins
5.40%
LAST: $514.24 (+2.20%) • MKT CAP: $231.94B
net-margins
20.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EMN VS. LIN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | EMN | LIN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 21.10% | 41.00% | -19.90 | LIN | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 4.80% | 13.10% | -8.30 | LIN | /roic <GO> |
| EV/EBITDA & P/E Valuation | 10.9x | 18.5x | -7.60 | EMN | /valuation <GO> |
| Free Cash Flow Yield | 5.46% | 2.19% | +3.27 | EMN | /fcf-yield <GO> |
| Operating Margin | 6.60% | 26.30% | -19.70 | LIN | /operating-margins <GO> |
| Net Profit Margin ACTIVE | 5.40% | 20.30% | -14.90 | LIN | /net-margins <GO> |
| Revenue Growth (YoY) | -6.70% | 3.00% | -9.70 | LIN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 4.90% | 1.21% | +3.69 | EMN | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.28 | 3.93 | -1.65 | LIN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | LIN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.10% | 6.90% | +0.20 | LIN | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 55.1 | 69.3 | -14.14 | LIN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.06 | 1.01 | +0.05 | EMN | /macro-sensitivity <GO> |
| Forward P/E Multiple | 15.3x | 31.2x | -15.90 | EMN | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $7.77B | $231.94B | -$224.17B | LIN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | EMN REV | LIN REV | EMN GROSS % | LIN GROSS % | EMN FCF | LIN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $8.75B | $33.99B | 21.1% | 44.0% | $424.0M | $5.09B |
| FY 2024 | $9.38B | $33.01B | 24.4% | 44.0% | $688.0M | $4.93B |
| FY 2023 | $9.21B | $32.85B | 44.0% | 44.0% | $959.5M | $7.83B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EMN // BETA 1.06
LIN // BETA 1.01